4.7 Review

Reprogramming of sentinel lymph node microenvironment during tumor metastasis

Journal

JOURNAL OF BIOMEDICAL SCIENCE
Volume 29, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12929-022-00868-1

Keywords

Lymph node; Immune; Metastasis; Microenvironment

Funding

  1. Ministry of Science and Technology, Taiwan [110-2320-B-400-016]
  2. Ministry of Health and Welfare, Taiwan [CA-111-PP-17]

Ask authors/readers for more resources

Lymphatic metastasis is a major cause of cancer-related deaths, and the molecular basis of this process is not well understood. Cancer cells invade the lymphatic system and enter the sentinel lymph node, where they modify the microenvironment and suppress anti-tumor immunity. Developing strategies to reverse these changes in the sentinel lymph node may reduce colonization and distant metastasis. Alternatively, nanotechnology-based approaches for targeted drug delivery to the lymph node could enhance the efficacy of cancer treatment by killing cancer cells on site and promoting antigen presentation for immune activation.
Metastasis is a major cause of death in patients with cancer. The two main routes for cancer cell dissemination are the blood and lymphatic systems. The underlying mechanism of hematogenous metastasis has been well characterized in the past few decades. However, our understanding of the molecular basis of lymphatic metastasis remains at a premature stage. Conceptually, cancer cells invade into lymphatic capillary, passively move to collecting lymphatic vessels, migrate into sentinel lymph node (SLN;, the first lymph node to which cancer cells spread from the primary tumor), and enter the blood circulatory system via the subclavian vein. Before arriving, cancer cells release specific soluble factors to modulate the microenvironment in SLN to establish a beachhead for successful colonization. After colonization, cancer cells inhibit anti-tumor immunity by inducing the recruitment of regulatory T cell and myeloid-derived suppressor cells, suppressing the function of dendritic cell and CD8(+) T cell, and promoting the release of immunosuppressive cytokines. The development of novel strategies to reverse cancer cell-triggered SLN remodeling may re-activate immunity to reduce beachhead buildup and distant metastasis. In addition to being a microanatomic location for metastasis, the SLN is also an important site for immune modulation. Nanotechnology-based approaches to deliver lymph node-tropic antibodies or drug-conjugated nanoparticles to kill cancer cells on site are a new direction for cancer treatment. Conversely, the induction of stronger immunity by promoting antigen presentation in lymph nodes provides an alternate way to enhance the efficacy of immune checkpoint therapy and cancer vaccine. In this review article, we summarize recent findings on the reprogramming of SLN during lymphatic invasion and discuss the possibility of inhibiting tumor metastasis and eliciting anti-tumor immunity by targeting SLN.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available